BioNTech SE BNTX
NASDAQ BNTX
$110.89 -2.23 (-1.97%)
At close: Aug 20, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) EPS (Diluted) (2018 - 2025)

BioNTech SE (BNTX) EPS (Diluted) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.23
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.33
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.19
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.15
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 Roivant Sciences 26.52 Bn 26.52 Bn 1.16 Mn -0.40

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.73
Sep 30, 2025 0.38
Jun 30, 2025 -1.97
Mar 31, 2025 -2.08
Dec 31, 2024 1.52
Sep 30, 2024 0.54
Jun 30, 2024 -3.57
Mar 31, 2024 -1.56
Dec 31, 2023 3.85
Sep 30, 2023 1.28
Jun 30, 2023 -2.76
Mar 31, 2023 3.92
Dec 31, 2022 16.61
Sep 30, 2022 12.05
Jun 30, 2022 12.19
Mar 31, 2022 27.39
Dec 31, 2021 0.00
Sep 30, 2021 29.06
Jun 30, 2021 25.48
Mar 31, 2021 10.47